Mark S. Schroeder, EVP, President Diagnostics & COO at LABCORP HOLDINGS INC. (LH), sold 10,678 shares at $249.23 ($2.7M) on 2025-02-28, disclosed to the SEC on 2025-03-04.
Scheduled sale ($2.7M) by EVP, President Diagnostics & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $249.23 | 5,339 | $1.3M | 50.0% |
| 2 | $249.23 | 5,339 | $1.3M | 50.0% |
| Total | $249.23 avg | 10,678 | $2.7M | 100% |
| Filing → |
| LH | SELL | 2024-03-11 | $2.2M | — | Filing → |
| LH | SELL | 2023-05-22 | $325K | — | Filing → |
| LH | SELL | 2023-04-03 | $1.8M | — | Filing → |